New treatment option for Adolescent Alcohol Use
Official title Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
ClinicalTrials.gov ID: NCT07059078
What this study is testing
- What it's testing
- Alcohol use is prevalent in U.S. adolescents and contributes to adverse health outcomes in this population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- 12-17 years old
- Receiving pediatric primary care (PPC) services through the Johns Hopkins Medical Institute healthcare network
- Screening positive for moderate or high alcohol use risk as indicated by a S2BI score (i.e., showing any monthly alcohol use in the past 12 months)
- Able to speak, understand, and read in English or Spanish
- Able to provide assent, and receiving parental consent/permission to participate.
You likely can't join if
- Severe medical or psychiatric condition (e.g., behavioral dysregulation, psychopathology, or cognitive impairment that in the judgement of study or...
- Intellectual Disability (self-, caregiver-, or PPC-reported, or PPC-documented)
- Current or recent specialty substance use disorder treatment in the past 6 months
- Demonstrated current physiological alcohol withdrawal requiring urgent inpatient referral in the judgement of study or PPC physician
- Reported regular opioid, benzodiazepine, or cocaine use (\> weekly) or history of opioid, benzodiazepine, or cocaine overdose in the past 6 months
- Previous experience with a mindfulness-based intervention in the past 12 months
See the full eligibility criteria
- 12-17 years old
- Receiving pediatric primary care (PPC) services through the Johns Hopkins Medical Institute healthcare network
- Screening positive for moderate or high alcohol use risk as indicated by a S2BI score (i.e., showing any monthly alcohol use in the past 12 months)
- Able to speak, understand, and read in English or Spanish
- Able to provide assent, and receiving parental consent/permission to participate.
- Severe medical or psychiatric condition (e.g., behavioral dysregulation, psychopathology, or cognitive impairment that in the judgement of study or PPC provider may make participation hazardous [e.g., psychosis...
- Intellectual Disability (self-, caregiver-, or PPC-reported, or PPC-documented)
- Current or recent specialty substance use disorder treatment in the past 6 months
- Demonstrated current physiological alcohol withdrawal requiring urgent inpatient referral in the judgement of study or PPC physician
- Reported regular opioid, benzodiazepine, or cocaine use (\> weekly) or history of opioid, benzodiazepine, or cocaine overdose in the past 6 months
- Previous experience with a mindfulness-based intervention in the past 12 months
- Current regular meditation practice (\> 30 min/day for \> 5 days avg. over 30 days prior to screening).
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
- Belcamp, Maryland, United States
- Bowie, Maryland, United States
- Columbia, Maryland, United States
- Glen Burnie, Maryland, United States
- Hagerstown, Maryland, United States
- Nottingham, Maryland, United States
- Odenton, Maryland, United States
- Rockville, Maryland, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States; Belcamp, Maryland, United States; Bowie, Maryland, United States; Columbia, Maryland, United States; Glen Burnie, Maryland, United States; Hagerstown, Maryland, United States and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.